Trials / Withdrawn
WithdrawnNCT05009485
A Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAP
A Pre-post Intervention Study Evaluating Home-based Management of Patients With Chronic Obstructive Pulmonary Disease or Community Acquired Pneumonia
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Current Health · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Risk of rehospitalization within 30 days of discharge is higher than 20% in patients with chronic obstructive pulmonary disease (COPD) and up to 20% for patients with community acquired pneumonia (CAP). This pre-post intervention study aims to quantify the impact of continuous remote patient monitoring (RPM) on rates of hospital readmission for patients presenting with CAP or exacerbation of COPD and compare the intervention group to historical controls that did not have access to the intervention. We hypothesize that an intervention combining remote patient monitoring with the remote clinical services and escalation pathways available at SSH (including the Mobile Integrated Health (MIH) program) will reduce hospital readmission within the 30 days following hospital discharge compared to standard of care in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Current Health platform | A remote patient monitoring system which includes a small footprint device and tablet, combined with an AI-powered, cloud-based system driving advanced real-time and predictive analytics related to a patient's clinical condition. The wearable records heart rate, respiratory rate, oxygen saturation, skin temperature and step count. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2024-04-01
- Completion
- 2024-05-01
- First posted
- 2021-08-17
- Last updated
- 2021-11-17
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05009485. Inclusion in this directory is not an endorsement.